Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FENOFIBRIC ACID
- CKD-337(2) Drug-drug Interaction Study
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid
- Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male Volunteers
- A Bioequivalence Study Comparing HIP0901 Capsule With Lipidilsupra Tablet
- A Drug-Drug Interaction Study Between Fenofibric Acid and Efavirenz
- The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers
- AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis
- Study of Trilipix Effects on Lipids and Arteries
- Fasted Pharmacokinetic and Bioequivalency Study of Fenofibric Acid
- Bioequivalence Study of Fenofibric Acid Versus Tricor® (Fenofibrate)
- Four Arm Food Effect Study of Fenofibric Acid Tablets
- Fed Bioequivalence Study of Fenofibric Acid Versus TriCor® (Fenofibrate)
- Drug-Drug Interaction Study Between Fenofibric Acid and Efavirenz
- Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules
- Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg
- Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) and Rosuvastatin Calcium
- Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood
- Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood
- Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood
- Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.
Clinical trials list
click for details